Current advances in human-induced pluripotent stem cell-based models and therapeutic approaches for congenital heart disease

Current advances in human-induced pluripotent stem cell-based models and therapeutic approaches for congenital heart disease

Congenital heart disease (CHD) represents a significant risk factor with profound implications for neonatal survival rates and the overall well-being of adult patients. The emergence of induced pluripotent stem cells (iPSCs) and their derived cells, combined with CRISPR technology, high-throughput e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular and cellular biochemistry 2024-04
Hauptverfasser: Cao, Meiling, Liu, Yanshan, Sun, Ying, Han, Ruiyi, Jiang, Hongkun
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Molecular and cellular biochemistry
container_volume
creator Cao, Meiling
Liu, Yanshan
Sun, Ying
Han, Ruiyi
Jiang, Hongkun
description Congenital heart disease (CHD) represents a significant risk factor with profound implications for neonatal survival rates and the overall well-being of adult patients. The emergence of induced pluripotent stem cells (iPSCs) and their derived cells, combined with CRISPR technology, high-throughput experimental techniques, and organoid technology, which are better suited to contemporary research demands, offer new possibilities for treating CHD. Prior investigations have indicated that the paracrine effect of exosomes may hold potential solutions for therapeutic intervention. This review provides a summary of the advancements in iPSC-based models and clinical trials associated with CHD while elucidating potential therapeutic mechanisms and delineating clinical constraints pertinent to iPSC-based therapy, thereby offering valuable insights for further deliberation.
doi_str_mv 10.1007/s11010-024-04997-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3041231057</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3041231057</sourcerecordid><originalsourceid>FETCH-LOGICAL-c254t-ff09068e6c82741119556da87d193fe9ad33717b1b7b1528be2b3d95a127c5843</originalsourceid><addsrcrecordid>eNo9kEFv1DAQhS0EosvSP8Ch8pGLYSZO1vGxWtEWqRKX9mw59qQblDip7SBR9cfX2y0cRnOY957mfYx9QfiGAOp7QgQEAVUtoNZaiad3bIONkqLWqN-zDUgA0aJSZ-xTSr-hqAHxIzuT7U420MKGPe_XGClkbv0fGxwlPgR-WCcbxBD86sjzZVzjsMz5qEqZJu5oHEVnU7lNs6cxcRs8zweKdqE1D47bZYmzdYcS18-Ruzk8UBiyHfmBbMzcD4mK_zP70Nsx0fnb3rL7qx93-xtx--v65_7yVriqqbPoe9Cwa2nn2krViKibZudtqzxq2ZO2XkqFqsOuTFO1HVWd9LqxWCnXtLXcsq-n3PLV40opm2lIxxY20LwmI6HGSiIUdFtWnaQuzilF6s0Sh8nGvwbBHKmbE3VTqJtX6uapmC7e8tduIv_f8g-zfAGrIX9-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3041231057</pqid></control><display><type>article</type><title>Current advances in human-induced pluripotent stem cell-based models and therapeutic approaches for congenital heart disease</title><source>SpringerLink Journals - AutoHoldings</source><creator>Cao, Meiling ; Liu, Yanshan ; Sun, Ying ; Han, Ruiyi ; Jiang, Hongkun</creator><creatorcontrib>Cao, Meiling ; Liu, Yanshan ; Sun, Ying ; Han, Ruiyi ; Jiang, Hongkun</creatorcontrib><description>Congenital heart disease (CHD) represents a significant risk factor with profound implications for neonatal survival rates and the overall well-being of adult patients. The emergence of induced pluripotent stem cells (iPSCs) and their derived cells, combined with CRISPR technology, high-throughput experimental techniques, and organoid technology, which are better suited to contemporary research demands, offer new possibilities for treating CHD. Prior investigations have indicated that the paracrine effect of exosomes may hold potential solutions for therapeutic intervention. This review provides a summary of the advancements in iPSC-based models and clinical trials associated with CHD while elucidating potential therapeutic mechanisms and delineating clinical constraints pertinent to iPSC-based therapy, thereby offering valuable insights for further deliberation.</description><identifier>ISSN: 0300-8177</identifier><identifier>EISSN: 1573-4919</identifier><identifier>DOI: 10.1007/s11010-024-04997-z</identifier><identifier>PMID: 38635080</identifier><language>eng</language><publisher>Netherlands</publisher><ispartof>Molecular and cellular biochemistry, 2024-04</ispartof><rights>2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c254t-ff09068e6c82741119556da87d193fe9ad33717b1b7b1528be2b3d95a127c5843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38635080$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cao, Meiling</creatorcontrib><creatorcontrib>Liu, Yanshan</creatorcontrib><creatorcontrib>Sun, Ying</creatorcontrib><creatorcontrib>Han, Ruiyi</creatorcontrib><creatorcontrib>Jiang, Hongkun</creatorcontrib><title>Current advances in human-induced pluripotent stem cell-based models and therapeutic approaches for congenital heart disease</title><title>Molecular and cellular biochemistry</title><addtitle>Mol Cell Biochem</addtitle><description>Congenital heart disease (CHD) represents a significant risk factor with profound implications for neonatal survival rates and the overall well-being of adult patients. The emergence of induced pluripotent stem cells (iPSCs) and their derived cells, combined with CRISPR technology, high-throughput experimental techniques, and organoid technology, which are better suited to contemporary research demands, offer new possibilities for treating CHD. Prior investigations have indicated that the paracrine effect of exosomes may hold potential solutions for therapeutic intervention. This review provides a summary of the advancements in iPSC-based models and clinical trials associated with CHD while elucidating potential therapeutic mechanisms and delineating clinical constraints pertinent to iPSC-based therapy, thereby offering valuable insights for further deliberation.</description><issn>0300-8177</issn><issn>1573-4919</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kEFv1DAQhS0EosvSP8Ch8pGLYSZO1vGxWtEWqRKX9mw59qQblDip7SBR9cfX2y0cRnOY957mfYx9QfiGAOp7QgQEAVUtoNZaiad3bIONkqLWqN-zDUgA0aJSZ-xTSr-hqAHxIzuT7U420MKGPe_XGClkbv0fGxwlPgR-WCcbxBD86sjzZVzjsMz5qEqZJu5oHEVnU7lNs6cxcRs8zweKdqE1D47bZYmzdYcS18-Ruzk8UBiyHfmBbMzcD4mK_zP70Nsx0fnb3rL7qx93-xtx--v65_7yVriqqbPoe9Cwa2nn2krViKibZudtqzxq2ZO2XkqFqsOuTFO1HVWd9LqxWCnXtLXcsq-n3PLV40opm2lIxxY20LwmI6HGSiIUdFtWnaQuzilF6s0Sh8nGvwbBHKmbE3VTqJtX6uapmC7e8tduIv_f8g-zfAGrIX9-</recordid><startdate>20240418</startdate><enddate>20240418</enddate><creator>Cao, Meiling</creator><creator>Liu, Yanshan</creator><creator>Sun, Ying</creator><creator>Han, Ruiyi</creator><creator>Jiang, Hongkun</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240418</creationdate><title>Current advances in human-induced pluripotent stem cell-based models and therapeutic approaches for congenital heart disease</title><author>Cao, Meiling ; Liu, Yanshan ; Sun, Ying ; Han, Ruiyi ; Jiang, Hongkun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c254t-ff09068e6c82741119556da87d193fe9ad33717b1b7b1528be2b3d95a127c5843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cao, Meiling</creatorcontrib><creatorcontrib>Liu, Yanshan</creatorcontrib><creatorcontrib>Sun, Ying</creatorcontrib><creatorcontrib>Han, Ruiyi</creatorcontrib><creatorcontrib>Jiang, Hongkun</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular and cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cao, Meiling</au><au>Liu, Yanshan</au><au>Sun, Ying</au><au>Han, Ruiyi</au><au>Jiang, Hongkun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current advances in human-induced pluripotent stem cell-based models and therapeutic approaches for congenital heart disease</atitle><jtitle>Molecular and cellular biochemistry</jtitle><addtitle>Mol Cell Biochem</addtitle><date>2024-04-18</date><risdate>2024</risdate><issn>0300-8177</issn><eissn>1573-4919</eissn><abstract>Congenital heart disease (CHD) represents a significant risk factor with profound implications for neonatal survival rates and the overall well-being of adult patients. The emergence of induced pluripotent stem cells (iPSCs) and their derived cells, combined with CRISPR technology, high-throughput experimental techniques, and organoid technology, which are better suited to contemporary research demands, offer new possibilities for treating CHD. Prior investigations have indicated that the paracrine effect of exosomes may hold potential solutions for therapeutic intervention. This review provides a summary of the advancements in iPSC-based models and clinical trials associated with CHD while elucidating potential therapeutic mechanisms and delineating clinical constraints pertinent to iPSC-based therapy, thereby offering valuable insights for further deliberation.</abstract><cop>Netherlands</cop><pmid>38635080</pmid><doi>10.1007/s11010-024-04997-z</doi></addata></record>
fulltext fulltext
identifier ISSN: 0300-8177
ispartof Molecular and cellular biochemistry, 2024-04
issn 0300-8177
1573-4919
language eng
recordid cdi_proquest_miscellaneous_3041231057
source SpringerLink Journals - AutoHoldings
title Current advances in human-induced pluripotent stem cell-based models and therapeutic approaches for congenital heart disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T04%3A51%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20advances%20in%20human-induced%20pluripotent%20stem%20cell-based%20models%20and%20therapeutic%20approaches%20for%20congenital%20heart%20disease&rft.jtitle=Molecular%20and%20cellular%20biochemistry&rft.au=Cao,%20Meiling&rft.date=2024-04-18&rft.issn=0300-8177&rft.eissn=1573-4919&rft_id=info:doi/10.1007/s11010-024-04997-z&rft_dat=%3Cproquest_cross%3E3041231057%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3041231057&rft_id=info:pmid/38635080&rfr_iscdi=true